282
views
0
recommends
+1 Recommend
0 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Rotenone, Paraquat, and Parkinson’s Disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Mitochondrial dysfunction and oxidative stress are pathophysiologic mechanisms implicated in experimental models and genetic forms of Parkinson’s disease (PD). Certain pesticides may affect these mechanisms, but no pesticide has been definitively associated with PD in humans.

          Objectives

          Our goal was to determine whether pesticides that cause mitochondrial dysfunction or oxidative stress are associated with PD or clinical features of parkinsonism in humans.

          Methods

          We assessed lifetime use of pesticides selected by mechanism in a case–control study nested in the Agricultural Health Study (AHS). PD was diagnosed by movement disorders specialists. Controls were a stratified random sample of all AHS participants frequency-matched to cases by age, sex, and state at approximately three controls: one case.

          Results

          In 110 PD cases and 358 controls, PD was associated with use of a group of pesticides that inhibit mitochondrial complex I [odds ratio (OR) = 1.7; 95% confidence interval (CI), 1.0–2.8] including rotenone (OR = 2.5; 95% CI, 1.3–4.7) and with use of a group of pesticides that cause oxidative stress (OR = 2.0; 95% CI, 1.2–3.6), including paraquat (OR = 2.5; 95% CI, 1.4–4.7).

          Conclusions

          PD was positively associated with two groups of pesticides defined by mechanisms implicated experimentally—those that impair mitochondrial function and those that increase oxidative stress—supporting a role for these mechanisms in PD pathophysiology.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

          Few detailed clinico-pathological correlations of Parkinson's disease have been published. The pathological findings in 100 patients diagnosed prospectively by a group of consultant neurologists as having idiopathic Parkinson's disease are reported. Seventy six had nigral Lewy bodies, and in all of these Lewy bodies were also found in the cerebral cortex. In 24 cases without Lewy bodies, diagnoses included progressive supranuclear palsy, multiple system atrophy, Alzheimer's disease, Alzheimer-type pathology, and basal ganglia vascular disease. The retrospective application of recommended diagnostic criteria improved the diagnostic accuracy to 82%. These observations call into question current concepts of Parkinson's disease as a single distinct morbid entity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Diagnostic criteria for Parkinson disease.

            The clinical diagnosis of Parkinson disease (PD) is based on the identification of some combination of the cardinal motor signs of bradykinesia, rigidity, tremor, and postural instability, but few attempts have been made to develop explicit diagnostic criteria. We propose a clinical diagnostic classification based on a comprehensive review of the literature regarding the sensitivity and specificity of the characteristic clinical features of PD. Three levels of diagnostic confidence are differentiated: Definite, Probable, and Possible. The diagnoses of Possible and Probable PD are based on clinical criteria alone. Neuropathologic confirmation is required for the diagnosis of Definite PD in patients with the clinical diagnosis of Possible or Probable PD. Criteria for histopathologic confirmation of PD are also presented.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

              Parkinson disease (PD) is associated with progressive loss of dopaminergic neurons in the substantia nigra, as well as with more-widespread neuronal changes that cause complex and variable motor and nonmotor symptoms. Recent rapid advances in PD genetics have revealed a prominent role for mitochondrial dysfunction in the pathogenesis of the disease, and the products of several PD-associated genes, including SNCA, Parkin, PINK1, DJ-1, LRRK2 and HTR2A, show a degree of localization to the mitochondria under certain conditions. Impaired mitochondrial function is likely to increase oxidative stress and might render cells more vulnerable to this and other related processes, including excitotoxicity. The mitochondria, therefore, represent a highly promising target for the development of disease biomarkers by use of genetic, biochemical and bioimaging approaches. Novel therapeutic interventions that modify mitochondrial function are currently under development, and a large phase III clinical trial is underway to examine whether high-dose oral coenzyme Q10 will slow disease progression. In this Review, we examine evidence for the roles of mitochondrial dysfunction and increased oxidative stress in the neuronal loss that leads to PD and discuss how this knowledge might further improve patient management and aid in the development of 'mitochondrial therapy' for PD.
                Bookmark

                Author and article information

                Journal
                Environ Health Perspect
                Environmental Health Perspectives
                National Institute of Environmental Health Sciences
                0091-6765
                1552-9924
                June 2011
                26 January 2011
                : 119
                : 6
                : 866-872
                Affiliations
                [1 ] The Parkinson’s Institute, Sunnyvale, California, USA
                [2 ] Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA
                [3 ] Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii, USA
                [4 ] Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
                [5 ] Departments of Neurology and Clinical and Molecular Neurogenetics, University of Lubeck, Lubeck, Germany
                [6 ] Institute of Cognitive Neurology, Institute of Neuroscience, Favaloro University, Buenos Aires, Argentina
                [7 ] Westat Inc., Durham, North Carolina, USA
                [8 ] Center for Neurological Restoration, Cleveland Clinic, Cleveland, Ohio, USA
                [9 ] Department of Neurology, University of Kentucky, Lexington, Kentucky, USA
                [10 ] Biostatistics Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA
                [11 ] Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
                Author notes
                Address correspondence to C. Tanner, Parkinson’s Institute, 675 Almanor Ave., Sunnyvale, CA 94085 USA. Telephone: (408) 734-2800. Fax: (408) 734-8455. E-mail: ctannermd@ 123456aol.com

                C.T., W.L., C.M., H.F., W.R., and S.G., in addition to their listed affiliations, serve on advisory boards for various foundations and serve as consultants and receive financial support from many sources, including former and current welding products manufacturers and pharmaceutical companies who manufacture or do research on medications for Parkinson’s disease. The Parkinson’s Institute treats patients with PD. Westat is an employee-owned company. The other authors declare they have no actual or potential competing financial interests.

                Article
                ehp-119-866
                10.1289/ehp.1002839
                3114824
                21269927
                d4322a24-8abe-4e78-9c66-c72df0beda06
                This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI.
                History
                : 8 August 2010
                : 26 January 2011
                Categories
                Research

                Public health
                environmental epidemiology,agricultural epidemiology,aging,persistent organic pollutants,fungicides,pesticides,insecticides,epidemiology,herbicides

                Comments

                Comment on this article